CLINICAL_TRIALS
trial_result
· 2018-11-21
Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer [Phase 1]
Summary
Phase 1 trial update of ramucirumab (LY3009806) in participants with advanced hepatocellular carcinoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED | Results posted: 2018-11-21